THYRAGE is a EC funded H2020 research project that will investigate the effects of thyroid hormone on a wide range of age-related diseases, including osteoporosis, osteoarthritis, neurological disorders and sarcopenia. Knowledge generated in this innovative project is needed to develop new strategies to prevent and treat these diseases in the elderly.

Partners

Leiden University Medical Center

Leiden, The Netherlands

In the Leiden University Medical Center, patient care, scientific research and education are well integrated. 'Ageing' is one of the seven specific research themes in which the LUMC excels. In each of these themes, clinical and fundamental research from several departments is combined.

CNRS

Paris, France

CNRS is a state-funded science and technology establishment placed under the authorithy of the French Minister for Research. CNRS research units are located throughout France and employ a large body of tenured researchers, engineers and support staff. Laboratories are all on renewable four-year contracts, with bi-annual evaluation.

Imperial College London

London, United Kingdom

Imperial College London is a university of world class scholarship, education and research in science, engineering and medicine. It is consistently rated among the UK top three universities. The department of Medicine is one of the largest research organisations in the UK, with world-leading infrastructure supporting more than 200 principal investigators and their research laboratories .

The Department of Clinical Medicine and Surgery is located in the Medical Campus of the University of Naples "Federico II", a widely recognized world-leading centre of excellence in all aspects of medical education and research.

The IEM HAS is the leading multidisciplinary neuroscience research centre in Central-Europe and received the Centre of Excellence Award from the EU. Its activity focuses on basic biomedical research, primarily in the field of neuroscience, including studies on neurotransmission, learning and memory, behaviour, ischaemic and epileptic brain damage, ageing as well as the central and peripheral control of hormone secretion. 

Pepscan

Lelystad, the Netherlands

Pepscan Therapeutics is a biopharmaceutical SME with ~25 employees that is applying its profound understanding of peptides for the discovery of new therapeutic drug as well as for a range of specialty peptide products and services. Current projects focus on development of (CLIPS-based) therapeutic peptides interfering with Protein-Protein Interactions.